Trial reportInternational journal of impotence research2019
Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study.
Trial report in International journal of impotence research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02939495 (The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy in the Treatment of Men With Premature Ejaculation and Erectile Dysfunction), which is not on this map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy in the Treatment of Men With Premature Ejaculation and Erectile Dysfunction (DAP-SPEED Study)
Who cites it
9 citing papers in PubMed, 28 citations in OpenAlex.
- Transcutaneous electric nerve stimulation to treat patients with premature ejaculation: phase II clinical trial.International journal of impotence research · 2020Trial
- On-demand silodosin 4 mg vs dapoxetine 60 mg in treatment of primary premature ejaculation: A prospective randomized study.Arab journal of urology · 2026Article
- Evaluation of the transcutaneous posterior tibial nerve stimulation in the treatment of life long premature ejaculation: A randomized controlled trial.Arab journal of urology · 2025Article
- Prospective comparison of tadalafil 5 mg, dapoxetine 30 mg, and the combination of both in the treatment of premature ejaculation.Arab journal of urology · 2024Article
- The role of tyrosine hydroxylase within dapoxetine-assisted therapy against premature ejaculation.Molecular biology reports · 2023Article
- Current and emerging treatment options for premature ejaculation.Nature reviews. Urology · 2022Review
- Ejaculatory dysfunction in men with diabetes mellitus.World journal of diabetes · 2021Review
- Redefining a sexual medicine paradigm: subclinical premature ejaculation as a new taxonomic entity.Nature reviews. Urology · 2021Review
- An update on the treatment of premature ejaculation: A systematic review.Arab journal of urology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Premature ejaculation (PE) and erectile dysfunction (ED) are the most prevalent sexual disorders in men. ED is commonly reported among patients with PE. Although recent guidelines recommend to treat ED first in men with both PE and ED, this recommendation is not based on evidence and there are limited data about the efficacy and safety of dapoxetine/sildenafil combination therapy for these patients. The aim of this study is to evaluate the clinical efficacy and safety of the dapoxetine/sildenafil combination (Dapoxil
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.